Literature DB >> 18599822

Characterization of a mouse model of plague after aerosolization of Yersinia pestis CO92.

Stacy L Agar1, Jian Sha1, Sheri M Foltz1, Tatiana E Erova1, Kristin G Walberg1, Todd E Parham1, Wallace B Baze2, Giovanni Suarez1, Johnny W Peterson3,1, Ashok K Chopra3,1.   

Abstract

Yersinia pestis is a Gram-negative bacterium, and the causative agent of bubonic plague and pneumonic plague. Because of its potential use as a biological warfare weapon, the plague bacterium has been placed on the list of category A select agents. The dynamics of pneumonic infection following aerosolization of the highly virulent Y. pestis CO92 strain have been poorly studied; therefore, the purpose of this study was to determine the LD(50) dose, bacterial dissemination, cytokine/chemokine production and tissue damage in Swiss-Webster mice over a 72 h course of infection. We exposed mice in a whole-body Madison chamber to various doses of Y. pestis CO92 aerosolized by a Collison nebulizer, and determined that the LD(50) presented dose (Dp) of the bacterium in the lungs was 2.1 x 10(3) c.f.u. In a subsequent study, we infected mice at a Dp of 1.3 x 10(4) c.f.u., and harvested organs and blood at 1, 24, 48 and 72 h post-infection. Histopathological examination, in addition to measurement of bacterial dissemination and cytokine/chemokine analysis, indicated progressive tissue injury, and an increased number of animals succumbing to infection over the course of the experiment. Using these data, we were able to characterize the mouse plague model following aerosolization of Y. pestis CO92.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18599822     DOI: 10.1099/mic.0.2008/017335-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  46 in total

1.  Pulmonary infection by Yersinia pestis rapidly establishes a permissive environment for microbial proliferation.

Authors:  Paul A Price; Jianping Jin; William E Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-01       Impact factor: 11.205

Review 2.  Developing live vaccines against plague.

Authors:  Wei Sun; Kenneth L Roland; Roy Curtiss
Journal:  J Infect Dev Ctries       Date:  2011-09-14       Impact factor: 0.968

Review 3.  Considerations for Infectious Disease Research Studies Using Animals.

Authors:  Lesley A Colby; Lauriane E Quenee; Lois A Zitzow
Journal:  Comp Med       Date:  2017-06-01       Impact factor: 0.982

4.  High-throughput, signature-tagged mutagenic approach to identify novel virulence factors of Yersinia pestis CO92 in a mouse model of infection.

Authors:  Duraisamy Ponnusamy; Eric C Fitts; Jian Sha; Tatiana E Erova; Elena V Kozlova; Michelle L Kirtley; Bethany L Tiner; Jourdan A Andersson; Ashok K Chopra
Journal:  Infect Immun       Date:  2015-03-09       Impact factor: 3.441

5.  A novel post-exposure medical countermeasure L-97-1 improves survival and acute lung injury following intratracheal infection with Yersinia pestis.

Authors:  Constance N Wilson; Constance O Vance; Timothy M Doyle; David S Brink; George M Matuschak; Andrew J Lechner
Journal:  Innate Immun       Date:  2011-08-23       Impact factor: 2.680

6.  Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine.

Authors:  Tatiana E Erova; Jason A Rosenzweig; Jian Sha; Giovanni Suarez; Johanna C Sierra; Michelle L Kirtley; Christina J van Lier; Maxim V Telepnev; Vladimir L Motin; Ashok K Chopra
Journal:  Clin Vaccine Immunol       Date:  2012-12-12

7.  Amino acid substitutions in LcrV at putative sites of interaction with Toll-like receptor 2 do not affect the virulence of Yersinia pestis.

Authors:  Wei Sun; Roy Curtiss
Journal:  Microb Pathog       Date:  2012-07-24       Impact factor: 3.738

8.  A non-invasive in vivo imaging system to study dissemination of bioluminescent Yersinia pestis CO92 in a mouse model of pneumonic plague.

Authors:  Jian Sha; Jason A Rosenzweig; Michelle L Kirtley; Christina J van Lier; Eric C Fitts; Elena V Kozlova; Tatiana E Erova; Bethany L Tiner; Ashok K Chopra
Journal:  Microb Pathog       Date:  2012-10-09       Impact factor: 3.738

9.  Different pathologies but equal levels of responsiveness to the recombinant F1 and V antigen vaccine and ciprofloxacin in a murine model of plague caused by small- and large-particle aerosols.

Authors:  Richard J Thomas; Daniel Webber; Aaron Collinge; Anthony J Stagg; Stephen C Bailey; Alejandro Nunez; Amanda Gates; Pramukh N Jayasekera; Rosa R Taylor; Steve Eley; Richard W Titball
Journal:  Infect Immun       Date:  2009-02-02       Impact factor: 3.441

10.  Modeling the epidemiological history of plague in Central Asia: palaeoclimatic forcing on a disease system over the past millennium.

Authors:  Kyrre Linné Kausrud; Mike Begon; Tamara Ben Ari; Hildegunn Viljugrein; Jan Esper; Ulf Büntgen; Herwig Leirs; Claudia Junge; Bao Yang; Meixue Yang; Lei Xu; Nils Chr Stenseth
Journal:  BMC Biol       Date:  2010-08-27       Impact factor: 7.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.